Thorne HealthTech (NASDAQ:THRN) Updates FY 2023 Earnings Guidance

Thorne HealthTech (NASDAQ:THRN – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $0.37-$0.39 for the period, compared to the consensus estimate of $0.64. The company issued revenue guidance of $280.00 million-$290.00 million, compared to the consensus revenue estimate of $298.37 […]

Related Keywords

United States ,Thorne Healthtech ,Millennium Management ,Geode Capital Management ,Thorne Healthtech Inc ,Barclays Plc ,Atria Wealth Solutions Inc ,Thorne Healthtech Company Profile ,Virtu Financial ,Get Rating ,Capital Management ,Atria Wealth Solutions ,Wealth Solutions ,Thorne Healthtech Daily ,Nasdaq Thrn ,Thrn ,Medical ,Guidance ,Earnings ,Preannouncement ,